wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35803226-007F6B17-F512-41B9-9A77-59C8EB1A9140
Q35803226-007F6B17-F512-41B9-9A77-59C8EB1A9140
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-007F6B17-F512-41B9-9A77-59C8EB1A9140
Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.
P2860
Q35803226-007F6B17-F512-41B9-9A77-59C8EB1A9140
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-007F6B17-F512-41B9-9A77-59C8EB1A9140
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0513484969c17eea9af8c3c549de7e722d33f4db
P2860
Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies.